PDGFRB and melanoma: This is confirmed by the findings that, melanoma cells grown in MSC-conditioned medium, unlike control cells, do not express a reduction of PDGFR, EGFR and p-ERK after Vemurafenib treatment (Figure 3(D)), well characterised markers of melanoma resistance to Vemurafenib.25